Composition effects on the performance of dry powders for inhalation
Chronic respiratory diseases, such as asthma, represent a significant global health issue. Symptoms are commonly treated through inhalation therapy, enabling the delivery of the active pharmaceutical ingredient (API) directly to the lungs. Pulmonary drug delivery offers several advantages, including reduced risk of systemic side effects and a minimally invasive route of administration. Dry-powder
